An analysis of 96,000 HCQ patients, show increased risk of death

Louis Winthorpe III

Maybe we can put this issue to rest.

We were unable to confirm a benefit of hydroxychloroquine or chloroquine, when used alone or with a macrolide, on in-hospital outcomes for COVID-19. Each of these drug regimens was associated with decreased in-hospital survival and an increased frequency of ventricular arrhythmias when used for treatment of COVID-19.


Global Economics